HONG KONG -- Prenetics, the Hong Kong-based COVID-19 test provider that helped English football's Premier League resume matches, is planning an initial public offering as early as this year and is on track to close a $100 million pre-IPO funding round in the first quarter, according to people familiar with the discussions.
The latest fundraising by the 7-year-old startup backed by Jack Ma's Alibaba Hong Kong Entrepreneurs Fund will value it between $800 million and $900 million, a person familiar with the round said. This compares with a valuation above $300 million as of the company's last funding round in September.
